2m 2m 2m 2m 2m 2m 2m
Akso Health Sp ADR (AHG)
NASDAQ
$1.46+$0.01 (+0.69%)
Price as of Jun 03, 2026 4:10 PM EDT- $1.3BMarket Cap
- 5.07%1-Year Change
- Medical DistributionIndustry
Akso Health Sp ADR (AHG)
$1.46+$0.01 (+0.69%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 14.8M +512.08% | 2.4M -81.68% | 13.2M +108.86% | 6.3M +259.62% | |
Cost of Revenue | 15.1M +556.98% | 2.3M -80.76% | 11.9M +120.81% | 5.4M +890.66% | |
Gross Profit | -281,526 -330.51% | 122,132 -90.38% | 1.3M +38.50% | 916,226 -24.30% | |
Sales and Marketing Expense | 3.6M +2,062.11% | 168,421 +2,428.46% | 6,661 -97.24% | 240,927 -77.84% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | -421,186 -4.58% | |
Depreciation and Amortization Expense | 2.1M N/A | N/A N/A | N/A N/A | 18,390 +21.30% | |
Total Operating Expenses | 166.0M +1,795.20% | 8.8M -43.61% | 15.5M -7.82% | 16.9M -48.39% | |
Operating Profit | -166.3M +1,825.26% | -8.6M -39.45% | -14.3M -10.48% | -15.9M -48.43% | |
Interest Income | 47,091 -81.34% | 252,408 -83.60% | 1.5M +3,673.48% | 40,776 -59.25% | |
Interest Expense | N/A N/A | -27 N/A | N/A N/A | -700,000 -66.67% | |
Interest Income and Expense and Net | 47,091 -81.34% | 252,381 -83.60% | 1.5M +333.41% | -659,224 -67.04% | |
Total Nonoperating Income and Expense | 34,073 +107.51% | -453,751 -137.80% | 1.2M +253.79% | -780,546 +373.29% | |
Income before Taxes | -166.3M +1,728.80% | -9.1M -30.42% | -13.1M -21.84% | -16.7M -46.19% | |
Income Taxes | -30.8M -123,363.75% | 24,988 +42.39% | 17,549 -86.65% | 131,433 -72.79% | |
Extraordinary Items | 121.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -135.0M +1,327.01% | -9.5M +595.54% | -1.4M -91.93% | -16.9M -51.61% | |
Net Income from Continuing Operations Applicable to Common | -135.5M +1,385.93% | -9.1M -30.32% | -13.1M -21.74% | -16.7M -46.19% | |
Basic EPS and Net Income | -0.16 +128.57% | -0.07 +250.00% | -0.02 -92.86% | -0.28 -60.56% | |
Diluted EPS and Net Income | -0.16 +128.57% | -0.07 +250.00% | -0.02 -92.86% | -0.28 -60.56% | |
Basic Weighted Average Shares | 855.3M +504.37% | 141.5M +106.30% | 68.6M +15.07% | 59.6M +22.06% | |
Diluted Weighted Average Shares | 855.3M +504.37% | 141.5M +106.30% | 68.6M +15.07% | 59.6M +22.06% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 176.2M +106.91% | 85.2M +974.82% | 7.9M -63.86% | 21.9M +44.93% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 176.2M +106.91% | 85.2M +974.82% | 7.9M -63.86% | 21.9M +44.93% | |
Total Current Assets | 196.1M +38.10% | 142.0M +594.12% | 20.5M -59.58% | 50.6M +68.06% | |
Accumulated Depreciation | 1,612 N/A | N/A N/A | N/A N/A | 85,880 +31.96% | |
Property and Plant and Equipment and Net | 16,148 N/A | N/A N/A | N/A N/A | 55,433 -17.12% | |
Total Long-Term Assets | 18.8M -30.18% | 27.0M +93,870.03% | 28,698 -48.23% | 55,433 -17.12% | |
Total Assets | 215.0M +51.36% | 142.0M +594.12% | 20.5M -59.63% | 50.7M +59.95% | |
Income Taxes Payable | 2.0M +2,574.37% | 74,091 -22.83% | 96,005 -23.29% | 125,153 -70.18% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 47.2M +263.95% | |
Total Current Liabilities | 13.8M +284.34% | 3.6M -69.07% | 11.6M -69.73% | 38.4M +166.37% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 2.0M -90.00% | |
Total Long-Term Liabilities | 2.0M -99.31% | 290.2M N/A | N/A N/A | 2.6M -87.21% | |
Total Liabilities | 15.8M +339.69% | 3.6M -69.07% | 11.6M -69.73% | 38.4M +166.37% | |
Retained Earnings | -198.9M +211.15% | -63.9M +17.37% | -54.5M +2.56% | -53.1M +46.48% | |
Total Stockholders Equity | 199.1M +43.91% | 138.4M +1,485.82% | 8.7M -28.97% | 12.3M -28.88% | |
Total Shares Outstanding | 1.7B +278.70% | 437.2M +537.29% | 68.6M 0.00% | 68.6M +40.42% | |
Cash Flow | |||||
Cash from Operating Activities | 1.2M -12.88% | 1.4M +141.53% | -3.3M -62.29% | -8.6M -185.78% | |
Capital Expenditures | 154,460 N/A | N/A N/A | N/A N/A | 4,861 -97.57% | |
Cash from Investing Activities | -105.9M +93.55% | -54.7M -396.25% | 18.5M +192.52% | -20.0M +3,015,588.82% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 195.9M +48.79% | 131.7M +578.50% | -27.5M -179.11% | 34.8M +484.87% | |
Financials Ratio | |||||
Gross Margin | -1.91% -137.66% | 5.06% -47.45% | 9.63% -33.69% | 14.52% -78.95% | |
Operating Margin | -1,125.37% +214.54% | -357.78% +230.56% | -108.23% -57.14% | -252.54% -85.66% | |
Return on Assets | -75.62% +549.51% | -11.64% +204.54% | -3.82% -90.66% | -40.92% -35.34% | |
Return on Equity | -79.99% +521.96% | -12.86% -0.66% | -12.95% -88.65% | -114.03% +7.02% | |
Revenue Growth | 512.08% +726.91% | -81.68% -175.03% | 108.86% -58.07% | 259.62% +406.69% | |
Current Ratio | 14.20 -64.07% | 39.52 +2,144.35% | 1.76 +33.54% | 1.32 -36.91% | |
Cash Ratio | 12.76 -46.17% | 23.70 +3,375.51% | 0.68 +19.40% | 0.57 -45.59% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 4.01 +109.82% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.97 -6.70% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow